What is the pathophysiology of pulmonary edema in a pregnant woman after 20 weeks gestation who develops new‑onset hypertension and proteinuria (pre‑eclampsia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Pulmonary Edema in Preeclampsia

Pulmonary edema in preeclampsia results from widespread endothelial dysfunction that increases capillary permeability and reduces plasma oncotic pressure, compounded by impaired natriuretic peptide signaling that leads to sodium retention and intravascular volume expansion. 1

Primary Pathophysiologic Mechanisms

Endothelial Dysfunction as the Central Defect

  • Generalized maternal endothelial dysfunction is the fundamental mechanism underlying all maternal organ complications in preeclampsia, including pulmonary edema 2, 3.

  • The ischemic placenta releases excessive antiangiogenic factors—specifically soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng)—that disrupt the normal angiogenic balance and directly damage the maternal vascular endothelium 2.

  • This endothelial injury increases vascular permeability throughout the maternal circulation, allowing fluid extravasation from the intravascular space into the pulmonary interstitium 4, 3.

Impaired Natriuretic Peptide Signaling

  • Lower first-trimester NT-proBNP levels are associated with increased risk of preeclampsia, suggesting that deficient natriuretic peptide signaling contributes to the pathophysiology 1.

  • Genome-wide association studies have identified significant signals near genes encoding atrial natriuretic peptide, pro-BNP, and natriuretic peptide receptor C, with evidence that higher genetically predicted natriuretic peptide levels protect against hypertensive disorders of pregnancy 1.

  • Impaired natriuretic peptide function leads to inadequate sodium excretion, resulting in sodium retention and expansion of intravascular volume that predisposes to pulmonary edema 1.

Hemodynamic Alterations

  • Women who develop preeclampsia demonstrate attenuated reductions in systemic vascular resistance and impaired tolerance to the physiologic plasma volume expansion of pregnancy 1.

  • Defective spiral artery remodeling in the placenta creates higher vascular resistance, contributing to elevated systemic blood pressure and increased hydrostatic pressure in the pulmonary capillaries 3.

  • Severe hypertension (≥160/110 mmHg) further elevates pulmonary capillary hydrostatic pressure, overwhelming the capacity of pulmonary lymphatics to clear interstitial fluid 1, 3.

Contributing Factors to Pulmonary Edema

Reduced Plasma Oncotic Pressure

  • Significant proteinuria (≥0.3 g/day) causes hypoalbuminemia, reducing plasma oncotic pressure and favoring fluid movement from capillaries into the pulmonary interstitium 1.

  • Although proteinuria is present in only approximately 75% of preeclampsia cases, when present it substantially increases the risk of pulmonary edema 1, 5.

Hepatic Dysfunction and HELLP Syndrome

  • Liver involvement in preeclampsia—manifested as elevated transaminases (≥2× upper limit of normal) or HELLP syndrome (hemolysis, elevated liver enzymes, low platelets)—can further reduce hepatic albumin synthesis, exacerbating hypoalbuminemia 1, 3.

  • Hepatic edema and hemorrhage contribute to right upper quadrant/epigastric pain, which is a clinical marker of severe disease 1.

Iatrogenic Volume Overload

  • Administration of intravenous fluids or ergot derivatives for postpartum hemorrhage treatment can precipitate or worsen pulmonary edema in women with preeclampsia 1.

  • The postpartum period carries the highest risk for pulmonary edema, as blood pressure typically rises in the first week after delivery, with peak risk occurring 1-6 days postpartum 1.

Microvascular Dysfunction

  • Preeclampsia involves dysfunction of multiple microvascular beds—renal, cerebral, hepatic, and pulmonary—all contributing to the clinical manifestations 4.

  • Subclinical microvascular dysfunction likely occurs in parallel with, or even precedes, the development of overt cardiovascular symptoms 4.

  • The pulmonary microcirculation is particularly vulnerable because increased capillary permeability combined with elevated hydrostatic pressure creates ideal conditions for alveolar flooding 4, 3.

Clinical Recognition of Pulmonary Edema Risk

Severity Criteria Indicating High Risk

  • Acute pulmonary edema is itself a severity criterion for preeclampsia and mandates immediate delivery regardless of gestational age 1, 3.

  • Other severity features that increase pulmonary edema risk include: severe hypertension (≥160/110 mmHg), thrombocytopenia (<100,000/μL), progressive renal dysfunction (creatinine ≥1.1 mg/dL or doubling of baseline), and HELLP syndrome 1, 5, 3.

Common Pitfall

  • Peripheral edema is nonspecific and should not be used diagnostically for preeclampsia, as it occurs in many normal pregnancies; however, new-onset lower extremity edema combined with hypertension after 20 weeks should prompt immediate evaluation for preeclampsia 1, 5.

Cerebral Manifestations of the Same Pathophysiology

  • The same endothelial dysfunction causing pulmonary edema also produces cerebral edema, manifesting as headache, visual disturbances (including occipital lobe blindness), hyperreflexia with clonus, and convulsions (eclampsia) 1, 3.

  • Importantly, eclampsia can occur without severe hypertension—34% of eclamptic women had maximum diastolic blood pressure ≤100 mmHg—underscoring that endothelial dysfunction rather than blood pressure elevation alone drives organ complications 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathogenesis of preeclampsia.

Annual review of pathology, 2010

Research

Preeclampsia: an update.

Acta anaesthesiologica Belgica, 2014

Research

Maternal microvascular dysfunction during preeclamptic pregnancy.

Clinical science (London, England : 1979), 2021

Guideline

Preeclampsia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a woman who develops pre‑eclampsia after 20 weeks gestation with new‑onset hypertension, proteinuria, and elevated serum creatinine, will her renal function normalize after delivery?
Is a woman at 33 weeks gestation with hypertension (High Blood Pressure) and significant proteinuria (4+ protein in urine) an indication for Cesarean Section (CS)?
What is the standard of care for a 35-year-old female, 32 weeks pregnant with twins, with a history of laparoscopic adjustable gastric band (LAGB) procedure, diagnosed with preeclampsia with severe features and Hemolysis, Elevated Liver enzymes, and Low Platelet count (HELLP) syndrome, who develops signs and symptoms of sepsis and bowel perforation post-delivery via cesarean section (C-section), with laboratory results indicating hyperthermia, tachypnea, and elevated lactic acid, and imaging studies showing pneumoperitoneum, dilated bowel, and free air under the diaphragm?
How to manage a pregnant patient at 36.5 weeks gestation with new-onset proteinuria and symptoms concerning for preeclampsia?
In a patient who is 29 weeks + 6⁄7 days pregnant with severe pre‑eclampsia and a breech‑presenting fetus, should delivery be performed now?
For a patient admitted with hypernatremia, what is the appropriate level of care (ICU, step‑down unit, or regular medical floor) based on serum sodium concentration, rate of rise, and neurologic or hemodynamic stability?
For an elderly nursing‑facility patient with postoperative pain who cannot receive IV ketorolac, what oral rescue analgesic regimen and scheduled multimodal analgesia plan should be used?
What is vitamin K2 (menaquinone)?
What is the appropriate evaluation and treatment for an adult male with acute orchitis presenting with sudden scrotal pain, swelling, and erythema?
What is the mechanism of action of vitamin K2 (menaquinone)?
What is the recommended evaluation and initial management for a patient presenting with upper‑extremity edema?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.